SINGAPORE, Sept 14 — The Health Sciences Authority today granted interim authorisation for Moderna's updated vaccine, which can target both the original Sars-CoV-2 coronavirus as well as the Omicron BA.1 strain.
Its interim approval was granted under the Pandemic Special Access Route, which facilitates early access to critical novel vaccines and medicine during a pandemic.“Official vaccination recommendations using this booster vaccine will be issued by the expert committee on Covid-19 vaccination and the Ministry of Health in due time,” HSA said.
May be effective against other variants HSA’s clinical review was based on an ongoing trial in its second and third phase conducted by Moderna in individuals aged 18 and above.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: malaymail - 🏆 1. / 86 Read more »
Source: malaysiakini - 🏆 20. / 51 Read more »
Source: malaysiakini - 🏆 20. / 51 Read more »
Source: malaysiakini - 🏆 20. / 51 Read more »
Source: malaysiakini - 🏆 20. / 51 Read more »